$PMNT

Perfect Moment Ltd. (PMNT): Results of Operations and Financial Condition

Perfect Moment Ltd. (PMNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Perfect Moment Reports Fiscal Q1 2027 Results LONDON—August 17, 2026—Perfect Moment Ltd. (OTC: PMNT) (“Perfect Moment” or the “Company”), the high-performance, luxury lifestyle brand that fuses technical excellence with fashion-led design

Original reporting
Published Aug 17, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PMNT
Neutral
medium confidence
Mentioned
$PMNT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PMNTNeutralMed
01

Why it matters

Key new information is the quantified quarter performance (revenue, gross margin, operating loss, net loss) and liquidity (cash, revolver draws, receivables, inventory), plus management’s stated focus on a September Fall/Winter 2026 launch.

02

Market read

Traders can update models for PMNT’s near-term risk profile using the new revenue/margin trajectory and cash/revolver usage, and position around the September collection and activation plan.

03

What to watch

Cash fell to $0.7M and the company drew additional revolver capacity in July; traders may need to monitor near-term liquidity and inventory sell-through into the winter season rather than just quarterly losses.

Relevance 7/10Novelty 7/10Timing: after-hours filing today, with September launch flagged as next catalyst

Background

The 8-K includes Exhibit 99.1 with fiscal Q1 2027 results for the quarter ended June 30, 2026, and management commentary on transitioning to a full-price luxury model.

Company-level read

Ticker impact

$PMNTNeutralMedium confidence
Context

Perfect Moment reported fiscal Q1 2027 results, with revenue down 21.9% to $1.2M and net loss improving to $3.5M, plus balance-sheet cash at $0.7M.

Expected impact

Near-term trading may hinge on whether the wholesale mix shift and September full-price brand transition can offset gross margin pressure and limited cash.

Evidence & confidence

This is a primary SEC 8-K with quantified P&L and liquidity changes, but it is an OTC microcap with no explicit forward guidance or consensus benchmark in the text.

Market effects

Signals ongoing margin and demand challenges for luxury apparel brands while wholesale channel build-out is being used to stabilize revenue.

No specific regional demand or regulatory driver disclosed beyond the company’s France-based brand narrative.

Limited broader market impact; primarily company-specific microcap liquidity and operating performance.

Counterpoint

Wholesale revenue surged 268% and net loss improved, suggesting the gross margin decline may be mix-driven and potentially reversible as the full-price model ramps.

Key entities

  • Perfect Moment Ltd.

    OTC-listed luxury outerwear and activewear brand reporting fiscal Q1 2027 results and balance-sheet updates.

  • Jane Gottschalk

    Co-Founder, Creative Director and President, commenting on the brand transition and September focus.

  • Chath Weerasinghe

    CFO and COO, discussing transformation execution, financing costs, and liquidity strengthening.

Related articles

$ARQMed

Arq (ARQ) Q2 2026 Earnings Call Transcript

Arq (ARQ) held its Q2 2026 earnings call, citing revenue of about $30 million, gross margin around 38.5% (up ~520 bps), and adjusted EBITDA of about $5.8 million. The company discussed PAC for PFAS for near-term compliance ahead of EPA PFAS rules, and reiterated full-year CapEx of $8 million to $10 million.

$AMGMedAI 8/10

AMG’s Alternatives Boom Powers Record Growth

Affiliated Managers Group (AMG) reported Q2 revenue of $640.7 million and record assets under management of $942.4 billion, beating analyst expectations, according to the company. Net income rose to $237 million and economic EPS to $8.29. Alternatives now drive over 60% of earnings. Analysts rate the stock Buy/Strong Buy; shares around $370 with a $370.86 consensus target.

$BKKTMedAI 8/10

Bakkt (BKKT) Q2 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q2 2026 revenue of $170.1 million, down 70% from $568.1 million, citing client transitions and weaker digital asset trading volumes. GAAP net income was $80.8 million, driven mainly by a $98.5 million non-cash gain from Transchem warrants. Total transacting volume was $168.8 million; management reiterated an EBITDA breakeven target in Q4 2026.

$MLABMedAI 8/10

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories (MLAB) reported Q1 FY2027 revenues of $60.1 million, up 1% year over year, with core organic growth of 0.4%. Adjusted operating income was $15.4 million, up 19.5%, and gross margin rose to 64.9%. Net leverage fell to 1.85x after $8.7 million debt repayment. SDC revenue was $24.5 million, down 3.6% organically.

$PLBYMedAI 8/10

Playboy (PLBY) Q2 2026 Earnings Call Transcript

Playboy Inc. (PLBY) reported Q2 2026 revenue of $31.2 million, up 11% year over year, driven by Honey Birdette. Net income was $200,000 versus a $7.7 million loss a year earlier. Adjusted EBITDA rose to $7 million. Management cited Honey Birdette revenue of $19.5 million and licensing revenue of $11.2 million, plus debt reduction to $144.9 million and a share repurchase plan.